0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Mental Health Medications Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-22Y18957
Home | Market Reports | Health| Mental Health
Global Mental Health Medications Market Research Report 2025
BUY CHAPTERS

Global Mental Health Medications Market Research Report 2025

Code: QYRE-Auto-22Y18957
Report
March 2025
Pages:108
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Mental Health Medications Market Size

The global market for Mental Health Medications was valued at US$ 15620 million in the year 2024 and is projected to reach a revised size of US$ 23130 million by 2031, growing at a CAGR of 6.2% during the forecast period.

Mental Health Medications Market

Mental Health Medications Market

Mental health medications are drugs used to treat mental disorders, mood disorders, and other psychological illnesses by regulating neurotransmitter levels or neural activity in the brain to improve symptoms.
North American market for Mental Health Medications is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Mental Health Medications is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Mental Health Medications include Pfizer, Teva, Bayer, Eli Lilly, GlaxoSmithKline, AbbVie, Otsuka Pharmaceutical, Novartis, Allergan, Johnson & Johnson, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Mental Health Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mental Health Medications.
The Mental Health Medications market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mental Health Medications market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mental Health Medications manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Mental Health Medications Market Report

Report Metric Details
Report Name Mental Health Medications Market
Accounted market size in year US$ 15620 million
Forecasted market size in 2031 US$ 23130 million
CAGR 6.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital
  • Pharmacy
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Teva, Bayer, Eli Lilly, GlaxoSmithKline, AbbVie, Otsuka Pharmaceutical, Novartis, Allergan, Johnson & Johnson, Oakwood Labs, Sumitomo Dainippon Pharma, Mylan, MedinCell, Bristol Myers Squibb, Claire Ellen, Sanofi S.A, Janssen, Lundbeck, Par Pharmaceutical, Meda AB, Alkermes, AstraZeneca, Sanis Health
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Mental Health Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Mental Health Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Mental Health Medications Market growing?

Ans: The Mental Health Medications Market witnessing a CAGR of 6.2% during the forecast period 2025-2031.

What is the Mental Health Medications Market size in 2031?

Ans: The Mental Health Medications Market size in 2031 will be US$ 23130 million.

Who are the main players in the Mental Health Medications Market report?

Ans: The main players in the Mental Health Medications Market are Pfizer, Teva, Bayer, Eli Lilly, GlaxoSmithKline, AbbVie, Otsuka Pharmaceutical, Novartis, Allergan, Johnson & Johnson, Oakwood Labs, Sumitomo Dainippon Pharma, Mylan, MedinCell, Bristol Myers Squibb, Claire Ellen, Sanofi S.A, Janssen, Lundbeck, Par Pharmaceutical, Meda AB, Alkermes, AstraZeneca, Sanis Health

What are the Application segmentation covered in the Mental Health Medications Market report?

Ans: The Applications covered in the Mental Health Medications Market report are Hospital, Pharmacy, Clinic, Others

What are the Type segmentation covered in the Mental Health Medications Market report?

Ans: The Types covered in the Mental Health Medications Market report are Antidepressants, Antipsychotics, Antianxiety Medications, Others

Recommended Reports

Mental Health Drugs

Sleep Disorder Treatments

Behavioral & Mood Disorders

1 Mental Health Medications Market Overview
1.1 Product Definition
1.2 Mental Health Medications by Type
1.2.1 Global Mental Health Medications Market Value Comparison by Type (2024 VS 2031)
1.2.2 Antidepressants
1.2.3 Antipsychotics
1.2.4 Antianxiety Medications
1.2.5 Others
1.3 Mental Health Medications by Application
1.3.1 Global Mental Health Medications Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Clinic
1.3.5 Others
1.4 Global Mental Health Medications Market Size Estimates and Forecasts
1.4.1 Global Mental Health Medications Revenue 2020-2031
1.4.2 Global Mental Health Medications Sales 2020-2031
1.4.3 Global Mental Health Medications Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Mental Health Medications Market Competition by Manufacturers
2.1 Global Mental Health Medications Sales Market Share by Manufacturers (2020-2025)
2.2 Global Mental Health Medications Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Mental Health Medications Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Mental Health Medications, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Mental Health Medications, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Mental Health Medications, Product Type & Application
2.7 Global Key Manufacturers of Mental Health Medications, Date of Enter into This Industry
2.8 Global Mental Health Medications Market Competitive Situation and Trends
2.8.1 Global Mental Health Medications Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Mental Health Medications Players Market Share by Revenue
2.8.3 Global Mental Health Medications Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Mental Health Medications Market Scenario by Region
3.1 Global Mental Health Medications Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Mental Health Medications Sales by Region: 2020-2031
3.2.1 Global Mental Health Medications Sales by Region: 2020-2025
3.2.2 Global Mental Health Medications Sales by Region: 2026-2031
3.3 Global Mental Health Medications Revenue by Region: 2020-2031
3.3.1 Global Mental Health Medications Revenue by Region: 2020-2025
3.3.2 Global Mental Health Medications Revenue by Region: 2026-2031
3.4 North America Mental Health Medications Market Facts & Figures by Country
3.4.1 North America Mental Health Medications Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Mental Health Medications Sales by Country (2020-2031)
3.4.3 North America Mental Health Medications Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Mental Health Medications Market Facts & Figures by Country
3.5.1 Europe Mental Health Medications Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Mental Health Medications Sales by Country (2020-2031)
3.5.3 Europe Mental Health Medications Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mental Health Medications Market Facts & Figures by Region
3.6.1 Asia Pacific Mental Health Medications Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Mental Health Medications Sales by Region (2020-2031)
3.6.3 Asia Pacific Mental Health Medications Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Mental Health Medications Market Facts & Figures by Country
3.7.1 Latin America Mental Health Medications Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Mental Health Medications Sales by Country (2020-2031)
3.7.3 Latin America Mental Health Medications Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Mental Health Medications Market Facts & Figures by Country
3.8.1 Middle East and Africa Mental Health Medications Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Mental Health Medications Sales by Country (2020-2031)
3.8.3 Middle East and Africa Mental Health Medications Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mental Health Medications Sales by Type (2020-2031)
4.1.1 Global Mental Health Medications Sales by Type (2020-2025)
4.1.2 Global Mental Health Medications Sales by Type (2026-2031)
4.1.3 Global Mental Health Medications Sales Market Share by Type (2020-2031)
4.2 Global Mental Health Medications Revenue by Type (2020-2031)
4.2.1 Global Mental Health Medications Revenue by Type (2020-2025)
4.2.2 Global Mental Health Medications Revenue by Type (2026-2031)
4.2.3 Global Mental Health Medications Revenue Market Share by Type (2020-2031)
4.3 Global Mental Health Medications Price by Type (2020-2031)
5 Segment by Application
5.1 Global Mental Health Medications Sales by Application (2020-2031)
5.1.1 Global Mental Health Medications Sales by Application (2020-2025)
5.1.2 Global Mental Health Medications Sales by Application (2026-2031)
5.1.3 Global Mental Health Medications Sales Market Share by Application (2020-2031)
5.2 Global Mental Health Medications Revenue by Application (2020-2031)
5.2.1 Global Mental Health Medications Revenue by Application (2020-2025)
5.2.2 Global Mental Health Medications Revenue by Application (2026-2031)
5.2.3 Global Mental Health Medications Revenue Market Share by Application (2020-2031)
5.3 Global Mental Health Medications Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Mental Health Medications Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Mental Health Medications Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Teva
6.2.1 Teva Company Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Mental Health Medications Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Teva Mental Health Medications Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Company Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Mental Health Medications Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bayer Mental Health Medications Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 Eli Lilly
6.4.1 Eli Lilly Company Information
6.4.2 Eli Lilly Description and Business Overview
6.4.3 Eli Lilly Mental Health Medications Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Eli Lilly Mental Health Medications Product Portfolio
6.4.5 Eli Lilly Recent Developments/Updates
6.5 GlaxoSmithKline
6.5.1 GlaxoSmithKline Company Information
6.5.2 GlaxoSmithKline Description and Business Overview
6.5.3 GlaxoSmithKline Mental Health Medications Sales, Revenue and Gross Margin (2020-2025)
6.5.4 GlaxoSmithKline Mental Health Medications Product Portfolio
6.5.5 GlaxoSmithKline Recent Developments/Updates
6.6 AbbVie
6.6.1 AbbVie Company Information
6.6.2 AbbVie Description and Business Overview
6.6.3 AbbVie Mental Health Medications Sales, Revenue and Gross Margin (2020-2025)
6.6.4 AbbVie Mental Health Medications Product Portfolio
6.6.5 AbbVie Recent Developments/Updates
6.7 Otsuka Pharmaceutical
6.7.1 Otsuka Pharmaceutical Company Information
6.7.2 Otsuka Pharmaceutical Description and Business Overview
6.7.3 Otsuka Pharmaceutical Mental Health Medications Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Otsuka Pharmaceutical Mental Health Medications Product Portfolio
6.7.5 Otsuka Pharmaceutical Recent Developments/Updates
6.8 Novartis
6.8.1 Novartis Company Information
6.8.2 Novartis Description and Business Overview
6.8.3 Novartis Mental Health Medications Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Novartis Mental Health Medications Product Portfolio
6.8.5 Novartis Recent Developments/Updates
6.9 Allergan
6.9.1 Allergan Company Information
6.9.2 Allergan Description and Business Overview
6.9.3 Allergan Mental Health Medications Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Allergan Mental Health Medications Product Portfolio
6.9.5 Allergan Recent Developments/Updates
6.10 Johnson & Johnson
6.10.1 Johnson & Johnson Company Information
6.10.2 Johnson & Johnson Description and Business Overview
6.10.3 Johnson & Johnson Mental Health Medications Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Johnson & Johnson Mental Health Medications Product Portfolio
6.10.5 Johnson & Johnson Recent Developments/Updates
6.11 Oakwood Labs
6.11.1 Oakwood Labs Company Information
6.11.2 Oakwood Labs Description and Business Overview
6.11.3 Oakwood Labs Mental Health Medications Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Oakwood Labs Mental Health Medications Product Portfolio
6.11.5 Oakwood Labs Recent Developments/Updates
6.12 Sumitomo Dainippon Pharma
6.12.1 Sumitomo Dainippon Pharma Company Information
6.12.2 Sumitomo Dainippon Pharma Description and Business Overview
6.12.3 Sumitomo Dainippon Pharma Mental Health Medications Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Sumitomo Dainippon Pharma Mental Health Medications Product Portfolio
6.12.5 Sumitomo Dainippon Pharma Recent Developments/Updates
6.13 Mylan
6.13.1 Mylan Company Information
6.13.2 Mylan Description and Business Overview
6.13.3 Mylan Mental Health Medications Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Mylan Mental Health Medications Product Portfolio
6.13.5 Mylan Recent Developments/Updates
6.14 MedinCell
6.14.1 MedinCell Company Information
6.14.2 MedinCell Description and Business Overview
6.14.3 MedinCell Mental Health Medications Sales, Revenue and Gross Margin (2020-2025)
6.14.4 MedinCell Mental Health Medications Product Portfolio
6.14.5 MedinCell Recent Developments/Updates
6.15 Bristol Myers Squibb
6.15.1 Bristol Myers Squibb Company Information
6.15.2 Bristol Myers Squibb Description and Business Overview
6.15.3 Bristol Myers Squibb Mental Health Medications Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Bristol Myers Squibb Mental Health Medications Product Portfolio
6.15.5 Bristol Myers Squibb Recent Developments/Updates
6.16 Claire Ellen
6.16.1 Claire Ellen Company Information
6.16.2 Claire Ellen Description and Business Overview
6.16.3 Claire Ellen Mental Health Medications Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Claire Ellen Mental Health Medications Product Portfolio
6.16.5 Claire Ellen Recent Developments/Updates
6.17 Sanofi S.A
6.17.1 Sanofi S.A Company Information
6.17.2 Sanofi S.A Description and Business Overview
6.17.3 Sanofi S.A Mental Health Medications Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Sanofi S.A Mental Health Medications Product Portfolio
6.17.5 Sanofi S.A Recent Developments/Updates
6.18 Janssen
6.18.1 Janssen Company Information
6.18.2 Janssen Description and Business Overview
6.18.3 Janssen Mental Health Medications Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Janssen Mental Health Medications Product Portfolio
6.18.5 Janssen Recent Developments/Updates
6.19 Lundbeck
6.19.1 Lundbeck Company Information
6.19.2 Lundbeck Description and Business Overview
6.19.3 Lundbeck Mental Health Medications Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Lundbeck Mental Health Medications Product Portfolio
6.19.5 Lundbeck Recent Developments/Updates
6.20 Par Pharmaceutical
6.20.1 Par Pharmaceutical Company Information
6.20.2 Par Pharmaceutical Description and Business Overview
6.20.3 Par Pharmaceutical Mental Health Medications Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Par Pharmaceutical Mental Health Medications Product Portfolio
6.20.5 Par Pharmaceutical Recent Developments/Updates
6.21 Meda AB
6.21.1 Meda AB Company Information
6.21.2 Meda AB Description and Business Overview
6.21.3 Meda AB Mental Health Medications Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Meda AB Mental Health Medications Product Portfolio
6.21.5 Meda AB Recent Developments/Updates
6.22 Alkermes
6.22.1 Alkermes Company Information
6.22.2 Alkermes Description and Business Overview
6.22.3 Alkermes Mental Health Medications Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Alkermes Mental Health Medications Product Portfolio
6.22.5 Alkermes Recent Developments/Updates
6.23 AstraZeneca
6.23.1 AstraZeneca Company Information
6.23.2 AstraZeneca Description and Business Overview
6.23.3 AstraZeneca Mental Health Medications Sales, Revenue and Gross Margin (2020-2025)
6.23.4 AstraZeneca Mental Health Medications Product Portfolio
6.23.5 AstraZeneca Recent Developments/Updates
6.24 Sanis Health
6.24.1 Sanis Health Company Information
6.24.2 Sanis Health Description and Business Overview
6.24.3 Sanis Health Mental Health Medications Sales, Revenue and Gross Margin (2020-2025)
6.24.4 Sanis Health Mental Health Medications Product Portfolio
6.24.5 Sanis Health Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mental Health Medications Industry Chain Analysis
7.2 Mental Health Medications Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mental Health Medications Production Mode & Process Analysis
7.4 Mental Health Medications Sales and Marketing
7.4.1 Mental Health Medications Sales Channels
7.4.2 Mental Health Medications Distributors
7.5 Mental Health Medications Customer Analysis
8 Mental Health Medications Market Dynamics
8.1 Mental Health Medications Industry Trends
8.2 Mental Health Medications Market Drivers
8.3 Mental Health Medications Market Challenges
8.4 Mental Health Medications Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Mental Health Medications Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Mental Health Medications Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Mental Health Medications Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Mental Health Medications Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Mental Health Medications Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Mental Health Medications Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Mental Health Medications Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Mental Health Medications Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Mental Health Medications, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Mental Health Medications, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Mental Health Medications, Product Type & Application
 Table 12. Global Key Manufacturers of Mental Health Medications, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Mental Health Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mental Health Medications as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Mental Health Medications Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Mental Health Medications Sales by Region (2020-2025) & (K Units)
 Table 18. Global Mental Health Medications Sales Market Share by Region (2020-2025)
 Table 19. Global Mental Health Medications Sales by Region (2026-2031) & (K Units)
 Table 20. Global Mental Health Medications Sales Market Share by Region (2026-2031)
 Table 21. Global Mental Health Medications Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Mental Health Medications Revenue Market Share by Region (2020-2025)
 Table 23. Global Mental Health Medications Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Mental Health Medications Revenue Market Share by Region (2026-2031)
 Table 25. North America Mental Health Medications Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Mental Health Medications Sales by Country (2020-2025) & (K Units)
 Table 27. North America Mental Health Medications Sales by Country (2026-2031) & (K Units)
 Table 28. North America Mental Health Medications Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Mental Health Medications Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Mental Health Medications Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Mental Health Medications Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Mental Health Medications Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Mental Health Medications Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Mental Health Medications Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Mental Health Medications Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Mental Health Medications Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Mental Health Medications Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Mental Health Medications Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Mental Health Medications Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Mental Health Medications Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Mental Health Medications Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Mental Health Medications Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Mental Health Medications Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Mental Health Medications Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Mental Health Medications Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Mental Health Medications Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Mental Health Medications Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Mental Health Medications Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Mental Health Medications Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Mental Health Medications Sales (K Units) by Type (2020-2025)
 Table 51. Global Mental Health Medications Sales (K Units) by Type (2026-2031)
 Table 52. Global Mental Health Medications Sales Market Share by Type (2020-2025)
 Table 53. Global Mental Health Medications Sales Market Share by Type (2026-2031)
 Table 54. Global Mental Health Medications Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Mental Health Medications Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Mental Health Medications Revenue Market Share by Type (2020-2025)
 Table 57. Global Mental Health Medications Revenue Market Share by Type (2026-2031)
 Table 58. Global Mental Health Medications Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Mental Health Medications Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Mental Health Medications Sales (K Units) by Application (2020-2025)
 Table 61. Global Mental Health Medications Sales (K Units) by Application (2026-2031)
 Table 62. Global Mental Health Medications Sales Market Share by Application (2020-2025)
 Table 63. Global Mental Health Medications Sales Market Share by Application (2026-2031)
 Table 64. Global Mental Health Medications Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Mental Health Medications Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Mental Health Medications Revenue Market Share by Application (2020-2025)
 Table 67. Global Mental Health Medications Revenue Market Share by Application (2026-2031)
 Table 68. Global Mental Health Medications Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Mental Health Medications Price (US$/Unit) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Pfizer Mental Health Medications Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. Teva Company Information
 Table 76. Teva Description and Business Overview
 Table 77. Teva Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Teva Mental Health Medications Product
 Table 79. Teva Recent Developments/Updates
 Table 80. Bayer Company Information
 Table 81. Bayer Description and Business Overview
 Table 82. Bayer Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Bayer Mental Health Medications Product
 Table 84. Bayer Recent Developments/Updates
 Table 85. Eli Lilly Company Information
 Table 86. Eli Lilly Description and Business Overview
 Table 87. Eli Lilly Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Eli Lilly Mental Health Medications Product
 Table 89. Eli Lilly Recent Developments/Updates
 Table 90. GlaxoSmithKline Company Information
 Table 91. GlaxoSmithKline Description and Business Overview
 Table 92. GlaxoSmithKline Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. GlaxoSmithKline Mental Health Medications Product
 Table 94. GlaxoSmithKline Recent Developments/Updates
 Table 95. AbbVie Company Information
 Table 96. AbbVie Description and Business Overview
 Table 97. AbbVie Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. AbbVie Mental Health Medications Product
 Table 99. AbbVie Recent Developments/Updates
 Table 100. Otsuka Pharmaceutical Company Information
 Table 101. Otsuka Pharmaceutical Description and Business Overview
 Table 102. Otsuka Pharmaceutical Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Otsuka Pharmaceutical Mental Health Medications Product
 Table 104. Otsuka Pharmaceutical Recent Developments/Updates
 Table 105. Novartis Company Information
 Table 106. Novartis Description and Business Overview
 Table 107. Novartis Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Novartis Mental Health Medications Product
 Table 109. Novartis Recent Developments/Updates
 Table 110. Allergan Company Information
 Table 111. Allergan Description and Business Overview
 Table 112. Allergan Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Allergan Mental Health Medications Product
 Table 114. Allergan Recent Developments/Updates
 Table 115. Johnson & Johnson Company Information
 Table 116. Johnson & Johnson Description and Business Overview
 Table 117. Johnson & Johnson Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Johnson & Johnson Mental Health Medications Product
 Table 119. Johnson & Johnson Recent Developments/Updates
 Table 120. Oakwood Labs Company Information
 Table 121. Oakwood Labs Description and Business Overview
 Table 122. Oakwood Labs Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Oakwood Labs Mental Health Medications Product
 Table 124. Oakwood Labs Recent Developments/Updates
 Table 125. Sumitomo Dainippon Pharma Company Information
 Table 126. Sumitomo Dainippon Pharma Description and Business Overview
 Table 127. Sumitomo Dainippon Pharma Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Sumitomo Dainippon Pharma Mental Health Medications Product
 Table 129. Sumitomo Dainippon Pharma Recent Developments/Updates
 Table 130. Mylan Company Information
 Table 131. Mylan Description and Business Overview
 Table 132. Mylan Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Mylan Mental Health Medications Product
 Table 134. Mylan Recent Developments/Updates
 Table 135. MedinCell Company Information
 Table 136. MedinCell Description and Business Overview
 Table 137. MedinCell Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. MedinCell Mental Health Medications Product
 Table 139. MedinCell Recent Developments/Updates
 Table 140. Bristol Myers Squibb Company Information
 Table 141. Bristol Myers Squibb Description and Business Overview
 Table 142. Bristol Myers Squibb Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Bristol Myers Squibb Mental Health Medications Product
 Table 144. Bristol Myers Squibb Recent Developments/Updates
 Table 145. Claire Ellen Company Information
 Table 146. Claire Ellen Description and Business Overview
 Table 147. Claire Ellen Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Claire Ellen Mental Health Medications Product
 Table 149. Claire Ellen Recent Developments/Updates
 Table 150. Sanofi S.A Company Information
 Table 151. Sanofi S.A Description and Business Overview
 Table 152. Sanofi S.A Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Sanofi S.A Mental Health Medications Product
 Table 154. Sanofi S.A Recent Developments/Updates
 Table 155. Janssen Company Information
 Table 156. Janssen Description and Business Overview
 Table 157. Janssen Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Janssen Mental Health Medications Product
 Table 159. Janssen Recent Developments/Updates
 Table 160. Lundbeck Company Information
 Table 161. Lundbeck Description and Business Overview
 Table 162. Lundbeck Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. Lundbeck Mental Health Medications Product
 Table 164. Lundbeck Recent Developments/Updates
 Table 165. Par Pharmaceutical Company Information
 Table 166. Par Pharmaceutical Description and Business Overview
 Table 167. Par Pharmaceutical Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 168. Par Pharmaceutical Mental Health Medications Product
 Table 169. Par Pharmaceutical Recent Developments/Updates
 Table 170. Meda AB Company Information
 Table 171. Meda AB Description and Business Overview
 Table 172. Meda AB Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 173. Meda AB Mental Health Medications Product
 Table 174. Meda AB Recent Developments/Updates
 Table 175. Alkermes Company Information
 Table 176. Alkermes Description and Business Overview
 Table 177. Alkermes Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 178. Alkermes Mental Health Medications Product
 Table 179. Alkermes Recent Developments/Updates
 Table 180. AstraZeneca Company Information
 Table 181. AstraZeneca Description and Business Overview
 Table 182. AstraZeneca Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 183. AstraZeneca Mental Health Medications Product
 Table 184. AstraZeneca Recent Developments/Updates
 Table 185. Sanis Health Company Information
 Table 186. Sanis Health Description and Business Overview
 Table 187. Sanis Health Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 188. Sanis Health Mental Health Medications Product
 Table 189. Sanis Health Recent Developments/Updates
 Table 190. Key Raw Materials Lists
 Table 191. Raw Materials Key Suppliers Lists
 Table 192. Mental Health Medications Distributors List
 Table 193. Mental Health Medications Customers List
 Table 194. Mental Health Medications Market Trends
 Table 195. Mental Health Medications Market Drivers
 Table 196. Mental Health Medications Market Challenges
 Table 197. Mental Health Medications Market Restraints
 Table 198. Research Programs/Design for This Report
 Table 199. Key Data Information from Secondary Sources
 Table 200. Key Data Information from Primary Sources
 Table 201. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Mental Health Medications
 Figure 2. Global Mental Health Medications Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Mental Health Medications Market Share by Type: 2024 & 2031
 Figure 4. Antidepressants Product Picture
 Figure 5. Antipsychotics Product Picture
 Figure 6. Antianxiety Medications Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Mental Health Medications Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Mental Health Medications Market Share by Application: 2024 & 2031
 Figure 10. Hospital
 Figure 11. Pharmacy
 Figure 12. Clinic
 Figure 13. Others
 Figure 14. Global Mental Health Medications Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Mental Health Medications Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Mental Health Medications Sales (2020-2031) & (K Units)
 Figure 17. Global Mental Health Medications Average Price (US$/Unit) & (2020-2031)
 Figure 18. Mental Health Medications Report Years Considered
 Figure 19. Mental Health Medications Sales Share by Manufacturers in 2024
 Figure 20. Global Mental Health Medications Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Mental Health Medications Players: Market Share by Revenue in Mental Health Medications in 2024
 Figure 22. Mental Health Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Mental Health Medications Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Mental Health Medications Sales Market Share by Country (2020-2031)
 Figure 25. North America Mental Health Medications Revenue Market Share by Country (2020-2031)
 Figure 26. United States Mental Health Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Mental Health Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Mental Health Medications Sales Market Share by Country (2020-2031)
 Figure 29. Europe Mental Health Medications Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Mental Health Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Mental Health Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Mental Health Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Mental Health Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Mental Health Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Mental Health Medications Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Mental Health Medications Revenue Market Share by Region (2020-2031)
 Figure 37. China Mental Health Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Mental Health Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Mental Health Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Mental Health Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Mental Health Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan Mental Health Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Southeast Asia Mental Health Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Mental Health Medications Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Mental Health Medications Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Mental Health Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Mental Health Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Mental Health Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Colombia Mental Health Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Mental Health Medications Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Mental Health Medications Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Mental Health Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Mental Health Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Mental Health Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Mental Health Medications by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Mental Health Medications by Type (2020-2031)
 Figure 57. Global Mental Health Medications Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Mental Health Medications by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Mental Health Medications by Application (2020-2031)
 Figure 60. Global Mental Health Medications Price (US$/Unit) by Application (2020-2031)
 Figure 61. Mental Health Medications Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS